- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.10. | ABVC BIOPHARMA, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.08. | ABVC BIOPHARMA, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| ABVC BIOPHARMA Aktie jetzt für 0€ handeln | |||||
| 27.06. | ABVC BIOPHARMA, INC. - S-8, Securities to be offered to employees in employee benefit plans | 15 | SEC Filings | ||
| 04.06. | ABVC BIOPHARMA, INC. - 8-K, Current Report | 1 | SEC Filings |
4 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NANOREPRO | 1,610 | +4,55 % | NanoRepro: Erfolgreiche Transformation | Nach Darstellung der Analysten Matthias Greiffenberger und Cosmin Filker von GBC hat die NanoRepro AG mit Veröffentlichung der Halbjahreszahlen 2025 (per 30.6.) die bisherige Jahresprognose bestätigt.... ► Artikel lesen | |
| BIOXXMED | 0,100 | 0,00 % | HV-Termine: Hauptversammlungen bei bioXXmed, Borussia Dortmund, CureVac, elexxion, Nanofocus, NSI Asset, OTRS | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp.: Sirona Biochem Update to Shareholders on Financial Status and Operations | VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) ("Sirona") wishes to provide shareholders with a critical update on the company's financial... ► Artikel lesen | |
| REDHILL BIOPHARMA | 1,040 | 0,00 % | RedHill Biopharma Receives Nasdaq Staff Determination Notification | On October 16, 2025, the Company received a Staff Determination notification from The Nasdaq Stock Market LLC regarding continued non-compliance with the minimum... ► Artikel lesen | |
| CELLECTIS | 3,930 | -0,25 % | Why Cellectis Stock Is Trading Higher Today | ||
| ALTERITY THERAPEUTICS | 0,003 | -14,29 % | ALTERITY THERAPEUTICS LIMITED: Disclosure under Takeovers Panel GN 20 | ||
| BIORA THERAPEUTICS | 0,001 | -100,00 % | NSE - BIORA THERAPEUTICS, INC. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| SERES THERAPEUTICS | 24,650 | -1,00 % | Seres Therapeutics, Inc.: Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155 | CAMBRIDGE, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that CARB-X (Combating Antibiotic-Resistant Bacteria... ► Artikel lesen | |
| WINDTREE THERAPEUTICS | 0,108 | -1,82 % | Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee | The Company has a global license agreement for the acute pulmonary that could pay up to $78.9 million in development, regulatory and commercial milestones plus low double digit royalties The licensed... ► Artikel lesen | |
| ALTAMIRA THERAPEUTICS | 0,300 | 0,00 % | Altamira Therapeutics Ltd.: Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules | Demonstrated feasibility of effective DNA delivery with Company's xPhore nanoparticle technologyDNA delivery technology to be offered as GenePhore to biotech / pharma companiesAddressing large and growing... ► Artikel lesen | |
| MONOPAR THERAPEUTICS | 69,00 | -4,17 % | Monopar Therapeutics: Raymond James stuft Aktie wegen kommerzieller Bedenken herab | ||
| CLEARMIND MEDICINE | 0,170 | +0,83 % | Clearmind Medicine Inc.: Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder | Vancouver, Canada, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development... ► Artikel lesen | |
| SCISPARC | 2,460 | 0,00 % | SciSparc Ltd. - 6-K, Report of foreign issuer | ||
| ADITXT | 3,485 | 0,00 % | Aditxt, Inc. - 8-K, Current Report | ||
| ENSYSCE BIOSCIENCES | 1,790 | -10,05 % | Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs | ~Funding supports Phase 3 clinical development of PF614 and continued innovation in abuse- and overdose-resistant analgesics~ SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Ensysce Biosciences... ► Artikel lesen |
Das Unternehmen ABVC BIOPHARMA INC kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 2,700 Euro und damit -6,90 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ABVC BIOPHARMA INC finden Sie auf Wallstreet Online.